Active Ingredient (In Each Tablet)
Sennosides 8.6 mg
The following Structured Product Label (SPL) was submitted to the FDA by Guardian Drug Company for the product Senna-lax (NDC 53041-159). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding, ask a health professional before use, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Sennosides 8.6 mg
Laxative
relieves: occasional constipation (irregularity)
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
keep out of reach of children. In case of overdose, get medical help or contact a poison control center immediately.
| adults and children 12 years and over | 2 tablets once daily (maximum: 4 tablets twice a day) |
| children 6 to under 12 years | 1 tablet once daily (maximum: 2 tablets twice a day) |
| children 2 to under 6 years | 1/2 tablet once daily (maximum: 1 tablet twice a day) |
| childrem under 2 years | ask a doctor |
crospovidone, dextrose, magnesium stearate, microcrystalline cellulose, pregelatinized starch
* Please review the disclaimer below.